-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Madrigal Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
- Madrigal Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $17.9M, a 41.4% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $77.1M, a 79.3% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $49.7M, a 57.3% increase from 2022.
- Madrigal Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31.6M, a 17.7% increase from 2021.
- Madrigal Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $26.9M, a 29.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)